Status | Study |
RECRUITING |
Study Name: European Cystinosis Cohort Condition: Date: 2022-03-11 |
Recruiting |
Study Name: Biomarker for Patient With Cystinosis Disease or Highly Suspected for Cystinosis Disease Condition: Cystine Storage Disease Cystinosis Date: 2016-07-12 |
Completed |
Study Name: Efficacy of Topical Cysteamine in Nephropathic Cyctinosis Condition: Nephropathic Cyctinosis Corneal Cystine Crystals Date: 2016-04-12 Interventions: Drug: Cysteamine Patients were asked to use topical cysteamine 0.55% eye drops every 2 hours while awake |
Completed |
Study Name: The Functional Consequences of the CTNS-deletion for the TRPV1-receptor in Cystinosis Patients Condition: Cystinosis Date: 2015-07-14 Interventions: Other: Challenge agent: capsaicin |
Withdrawn |
Study Name: Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis Condition: Cystinosis Myopathy Date: 2014-04-25 Interventions: Drug: rh Growth Hormone |
Terminated |
Study Name: A Cohort of Patients With Cystinosis : Compliance to Cysteamine and Neurological Complications Condition: Cystinosis Date: 2012-12-11 Interventions: Other: Cysteamine bitartrate No intervention |
Completed |
Study Name: Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis Condition: Cystinosis Date: 2012-12-05 Interventions: Drug: RP103 Q12H Other Name: (Cysteamine Delayed-release Capsules) |
Active, not recruiting |
Study Name: Open-Label Safety & Superior Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cystinosis Condition: Cystinosis Date: 2012-11-16 Interventions: Drug: RP103 Q12H Other Name: R |
Completed |
Study Name: N Acetyl Cysteine for Cystinosis Patients Condition: Renal Disease Cystinosis Date: 2012-05-19 Interventions: Drug: N acetyl cysteine N acet |
Completed |
Study Name: Study in Healthy Adults to Determine the Effect That Food Has on the Absorption and Delivery of the Drug Cystagon™ Condition: Cystinosis Nephropathic Cystinosis Date: 2011-09-09 Interventions: Drug: Cysteamine bitartrate 500 mg total, single dose taken orally on visits 2, 3 & 4 which must occ |